Prolerity Clinical Research

Prolerity is committed to expanding into a leading research institution management network, with a therapeutic scope covering complex and challenging Phase I-III studies, including NASH/NAFLD, cardiology, central nervous system, gastroenterology, metabolic diseases, and other therapeutic areas.